Umbrella branding in pharmaceutical markets

Area of Science:

• Marketing
• Pharmaceutical Economics
• Consumer Behavior

Background:

• Umbrella branding leverages a firm's established reputation across diverse product lines.
• Firms utilize umbrella branding to enhance market presence and consumer trust.
• Understanding the impact of non-prescription drug advertising on prescription drug choices is crucial.

Purpose of the Study:

• To investigate the influence of non-prescription drug advertising on consumer decisions for prescription drugs from the same firm.
• To quantify the effects of umbrella branding in the pharmaceutical sector.
• To assess the impact on market expansion and consumer welfare.

Main Methods:

• Utilized a natural experiment in Germany where consumer-directed prescription drug advertising is banned.
• Employed an instrumental variable approach leveraging exogenous seasonality in the non-prescription drug market to identify advertising spillovers.
• Estimated the causal effect of umbrella branding on market outcomes.

Main Results:

• Umbrella branding leads to significant market expansion, especially for generic pharmaceutical firms.
• Advertising spillovers from non-prescription to prescription drug markets were identified.
• A positive impact on consumer welfare was observed, particularly in under-treated therapeutic areas.

Conclusions:

• Umbrella branding is an effective strategy for market expansion in the pharmaceutical industry.
• The practice can enhance consumer welfare by increasing access and choice in specific therapeutic areas.
• Policy implications regarding pharmaceutical marketing and branding strategies warrant consideration.